ASTM D7709-2012(2017) 5625 Standard Test Methods for Measuring Water Vapor Transmission Rate (WVTR) of Pharmaceutical Bottles and Blisters《测量药瓶和水泡包装水蒸气透过性(WVTR)的标准试验方法》.pdf

《ASTM D7709-2012(2017) 5625 Standard Test Methods for Measuring Water Vapor Transmission Rate (WVTR) of Pharmaceutical Bottles and Blisters《测量药瓶和水泡包装水蒸气透过性(WVTR)的标准试验方法》.pdf》由会员分享，可在线阅读，更多相关《ASTM D7709-2012(2017) 5625 Standard Test Methods for Measuring Water Vapor Transmission Rate (WVTR) of Pharmaceutical Bottles and Blisters《测量药瓶和水泡包装水蒸气透过性(WVTR)的标准试验方法》.pdf（7页珍藏版）》请在麦多课文档分享上搜索。

1、Designation: D7709 12 (Reapproved 2017)Standard Test Methods forMeasuring Water Vapor Transmission Rate (WVTR) ofPharmaceutical Bottles and Blisters1This standard is issued under the fixed designation D7709; the number immediately following the designation indicates the year oforiginal adoption or,

2、in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. Asuperscript epsilon () indicates an editorial change since the last revision or reapproval.1. Scope1.1 The three test methods described herein are for mea-surement of water vapor trans

3、mission rates (WVTRs) ofhigh-barrier multiple-unit containers (bottles), high-barriersingle-unit containers (blisters), and quasi-barrier single-unitcontainers used for packaging pharmaceutical products. Thecontainers are tested closed and sealed. These test methods canbe used for all consumer-sized

4、 primary containers and bulkprimary containers of a size limited only by the dimensions ofthe equipment and the weighing capacity and sensitivity of thebalance.1.2 These test methods are intended to be of sufficientsensitivity and precision to allow clear discrimination amongthe levels of barrier pa

5、ckages currently available for pharma-ceutical products.1.3 There are three methods: Method A is for bottles,Method B is for formed barrier blisters, and Method C is forformed quasi-barrier blisters. Methods B and C can be adaptedfor use with flexible pouches.1.4 These test methods use gravimetric m

6、easurement todetermine the rate of weight gain as a result of water vaportransmission into the package and subsequent uptake by adesiccant enclosed within the package. The packages areexposed to environments typical of those used for acceleratedstability testing of drug products in the package (typi

7、cally40 C75 % relative humidity RH).1.5 For these methods, balance sensitivity, amount ofdesiccant, number of blisters per test unit, and weighingfrequency were developed in an experiment based on TestMethods E96/E96M.1.6 Test Methods E96/E96M gives specific instruction onthe interactions among weig

8、hing frequency, number of datapoints necessary to establish steady state, minimum weightgain in a weighing period, and balance sensitivity.1.7 The test methods in this standard were developedspecifically for pharmaceutical bottles and blisters as closedcontainer-closure systems. The experiment from

9、which themethods were developed provided an inter-laboratory studyfrom which the precision and bias statement was written. Thepackages in the study were small bottles and blisters usedregularly for pharmaceutical solid oral dosage forms.1.8 In spite of the specific nature of their application, the t

10、estmethods in this standard should be suitable for other pharma-ceutical packages and most types and sizes of other consumerpackages.1.9 The values stated in SI units are to be regarded as thestandard. No other units of measurement are included in thisstandard. The units of measure for bottles are m

11、illigrams perbottle per day (mg/bottle-day) and for blisters, milligrams perblister cavity per day (mg/cavity-day).These units may be usedfor both standard and referee testing.1.10 This standard does not purport to address all of thesafety concerns, if any, associated with its use. It is theresponsi

12、bility of the user of this standard to establish appro-priate safety, health and environmental practices and deter-mine the applicability of regulatory limitations prior to use.1.11 This international standard was developed in accor-dance with internationally recognized principles on standard-izatio

13、n established in the Decision on Principles for theDevelopment of International Standards, Guides and Recom-mendations issued by the World Trade Organization TechnicalBarriers to Trade (TBT) Committee.2. Referenced Documents2.1 ASTM Standards:2E96/E96M Test Methods for Water Vapor Transmission ofMat

14、erials3. Terminology3.1 Definitions:1These test methods are under the jurisdiction of ASTM Committee F02 onPrimary Barrier Packaging and is the direct responsibility of Subcommittee F02.10on Permeation.Current edition approved Aug. 1, 2017. Published August 2017. Originallyapproved in 2011. Last pre

15、vious edition approved in 2012 as D7709 12. DOI:10.1520/D7709-12R17.2For referenced ASTM standards, visit the ASTM website, www.astm.org, orcontact ASTM Customer Service at serviceastm.org. For Annual Book of ASTMStandards volume information, refer to the standards Document Summary page onthe ASTM w

16、ebsite.Copyright ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959. United StatesThis international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for theDevelopment o

17、f International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.13.1.1 barrier blister, nblister made from high-barriermaterial, formed and sealed so that the water vapor transmis-sion rate (WVTR) (when tested at 40 C75 % RH) i

18、s less than1.0 mg/cavity-day.3.1.2 blister, nformed, lidded and sealed plastic dome thatcontains the solid oral product (usually one unit).3.1.2.1 DiscussionSynonymous with cavity.3.1.3 card, ncontiguous group of blisters formed andsealed with lid in place.3.1.3.1 DiscussionThe card is a production

19、geometry thatis a convenient quantity for a dosage regimen. The number ofblisters per card commonly ranges from one to ten but may bemore. From a marketing and production point of view, the cardis the basic, irreducible number of blisters in a market orclinical trial package. The blister card may so

20、metimes bereferred to as the container.3.1.4 cavity, nsee blister.3.1.5 container, n(1) bottle that contains multiple units ofdrug product, or (2) a card of blisters formed and sealed withlid.3.1.6 quasi-barrier blister, nblister made from low-barriermaterials formed and sealed so that the WVTR (whe

21、n tested at40 C75 % RH) is greater than 1.0 mg/cavity-day.3.1.6.1 DiscussionAn example of this is 250 m (10 mil)poly(vinyl chloride) (PVC) formed into size zero blisters andsealed with aluminum foil lid.3.1.7 test specimen (or specimen), n(1) for bottles, thebottle is the test specimen and (2) for b

22、listers, the blister cardis the test specimen.3.1.7.1 DiscussionFor blisters, more than one card (orspecimen) may be grouped into a test unit for conducting thetest.3.1.8 test unit, n(1) for bottles, the bottle is the test unit aswell as being the test specimen and (2) for blisters, the test unitis

23、a group of test specimens (cards) processed together fortemperature and humidity exposure and weighing at each timepoint.3.1.8.1 DiscussionThe purpose of the test unit for blistersis to gain the advantage of additive weight gain resulting frommore blisters than are on a single card. Detailed discuss

24、ion ofthis point is available in Test Methods E96/E96M. The termtest unit when applied to bottles is simply to maintain congru-ence of naming among the three test methods.4. Summary of Test Method4.1 In MethodAfor bottles, desiccant is placed in the bottlewhich is then closed in the normal manner in

25、cluding anymembrane (tamper-evident or otherwise) sealed in place. Thedesiccant-filled bottle is stored in an environment at 40 C75% RH. The desiccant-filled bottle is weighed at prescribed timeintervals until steady-state weight gain is obtained. Oncesteady state is obtained, the bottles are weighe

26、d at fiveconsecutive time points.4.2 In Method B for barrier blisters, desiccant is placed inthe blister and the lid material is sealed in place usingequipment that is capable of filling and properly sealing thecontainers (or cards). The desiccant-filled blister card is storedin an environment at 40

27、 C75 % RH. The card of desiccantfilled blisters is weighed at prescribed time intervals untilsteady-state weight gain is obtained. Once steady-state isobtained, the blister cards are weighed at five consecutive timepoints.4.3 WVTR for Method A or B is calculated using linearregression of the weight

28、versus time. The number of blisterstested depends on the barrier characteristics of the material, thesize of the blister, and the sensitivity of the balance used in thetest.4.4 4.4 In Method C for quasi-barrier blisters, desiccant isplaced in the blister and the lid material is sealed in place using

29、equipment that is capable of correctly filling and sealing thecontainers (or cards). The desiccant-filled blister card is storedin an environment at 40 C75 % RH. The desiccant-filledblister card is weighed at zero time and 48 h (two days).At thistime, the difference in weight (the weight gain) in mg

30、/cavity-day is taken as the WVTR. The number of blisters testeddepends on the barrier characteristics of the material, the sizeof the blister, and the sensitivity of the balance used in the test.NOTE 1For this test method, the requirement of five consecutiveweighings is waived because the desiccant

31、quickly becomes saturatedwhen packed in a quasi-barrier package and stored at 40 C 75 % RH.During development of this test method, it appeared that after the secondday the weight gain displayed a curvilinear profile typical of approachingsaturation of the desiccant. To obtain five weighings within t

32、wo days is anunwieldy process and is likely to lack precision.5. Significance and Use5.1 The purpose of these test methods is to obtain reliablevalues for WVTR that can be used to discriminate amongbarrier packages for pharmaceutical products. These test meth-ods will establish a WVTR value that rep

33、resents the watervapor transmission of the container closure system beingevaluated. They are intended for use in evaluating orcomparing, or both, the water vapor barrier performance ofalternative packages for use in packaging of pharmaceuticalproducts.5.2 While these methods were developed for a spe

34、cific,limited application, they should be suitable for most types andsizes of consumer packages.6. Apparatus6.1 For weighing the test units in Method A, use a balancethat has sufficient capacity to weigh the total of bottle, cap, anddesiccant throughout the period of the test. The balance shallhave

35、sensitivity adequate to measure small differences inweight from one time point to the next. The balance sensitivityshall be smaller than5%ofthedifferences in weight from onetime point to the next. (For example, during development ofthis test method, a balance with capacity of 110 g andsensitivity of

36、 0.1 mg was found to be acceptable for a 60 CCbottle.)6.2 For weighing the test specimens in Methods B and C,use a balance that has sufficient capacity to weigh the closed,sealed blister test unit throughout the period of use. Thebalance shall have sensitivity adequate to measure smallD7709 12 (2017

37、)2differences in weight from one time interval to the next. Thebalance sensitivity shall be smaller than5%ofthedifferencesin weight from one time interval to the next. For example,during development of this method, a balance with capacity of110 g and sensitivity of 0.1 mg was found to be acceptable.

38、Test Methods B and C may require that the blister cards(containers) be bundled in multiples to achieve periodic weightgains of sufficient magnitude to use the balance sensitivity.When so bundled, these cards are called test units. TestMethods E96/E96M specify that the weight gain in eachweighing per

39、iod shall be 20 times the sensitivity of the balance.6.3 For exposure of packages to the test environment forMethodsA, B, and C, use a chamber capable of maintaining 406 2 C and 75 6 5 % RH. The humidification should beachieved with de-ionized water, or equivalent means, to limitcontamination from w

40、ater impurities.7. Reagents and Materials7.1 Purity of ReagentsReagent-grade chemicals shall beused in all tests. Unless otherwise indicated, it is intended thatall reagents conform to the specifications of the Committee ofAnalytical Reagents of the American Chemical Society wheresuch specifications

41、 are available.3Other grades may be used,provided it is first ascertained that the reagent is of sufficientlyhigh purity to permit its use without lessening the accuracy ofthe determination.7.2 Desiccant for Method ADuring development ofMethod A, anhydrous calcium chloride in granular form wasused a

42、s the desiccant. Other desiccants may be suitable; forexample, a molecular sieve or silica gel. If calcium chloride inany form, including anhydrous, is used it shall be pre-dried at215 6 5 C for 714 614 h to ensure that any hexahydratepresent is fully converted to the anhydrate. Cool the desiccantin

43、 a desiccator for at least 2 h before use.NOTE 2It has been shown4that anhydrous calcium chloride maycontain calcium hexahydrate, which loses water only when the tempera-ture reaches 200 C.7.3 Desiccant for Methods B and CDuring developmentof Method B, silica gel was used as the desiccant. It was us

44、edin a molded form to fit the size and shape of the blister used.Other desiccants may be suitable, for example, a molecularsieve. If silica gel is used, it shall be pre-dried in a circulatinghot air oven at one of two conditions: 155 6 5 C for 314 614hor1506 5 C for 414 614 h. Dry molecular sieve in

45、 a mufflefurnace at 595 6 25 C. Dry the 4A and 3A sieves for 314 614 h. Dry the 13X sieve for 514 614 h. Cool the desiccant ina desiccator for at least 2 h before use.8. Sampling, Test Specimens, and Test Units8.1 Method A (Bottles)Use 15 bottles and 15 closureschosen to represent the package form t

46、o be tested. Reserve thebottles for preparation at the time of testing. The bottles andclosures should be stored such that they will not be damaged;particularly the mating surfaces of bottle and closure. Preparethe test specimens by filling each bottle23 with desiccant thenclose the container in the

47、 appropriate manner as quickly aspossible, including any membrane seal (tamper-evident orotherwise), if appropriate. Filling of bottles shall be done in alow-humidity atmosphere (as low as possible, but not greaterthan 50 % RH). Close screw caps in accordance with the torquerecommendations in Table

48、1.8.2 Methods B and C (Blisters)Fill with pre-dried desic-cant and seal the blisters on equipment that is capable ofcorrectly filling and sealing the market or clinical trial package.The desiccant tablet should fill the cavity, but for practicalconsiderations, multiple fragments may be used. If frag

49、mentsare used, the total weight of desiccant shall be enough to meetthe quantity required to avoid partial saturation of the desiccantbefore completion of the test.8.3 Filling of blisters shall be done in a low-humidityatmosphere (as low as possible, but not greater than 50 % RH).8.4 Desiccants shall not be exposed to room humidity formore than 30 min before sealing.9. Calibration9.1 The weighing balance used to weigh the containers shallbe appropriately calibrated.9.2 The environmental chamber shall be appropriately cali-brated.